AzTrials
AzTrials

Total Knee AnthroplastyNCT07595861

Recovery Trajectories After Total Knee Arthroplasty

An observational study of Total Knee Anthroplasty and Patient Reported Outcome Measurements, run by Ondokuz Mayıs University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This prospective cohort study aimed to compare recovery trajectories following cruciate-retaining (CR) and posterior-stabilized (PS) total knee arthroplasty (TKA) using rehabilitation-centered patient-reported outcome measures (PROMs). Read more about this study

Who is it for?
Ages 50 to 65 yearsHealthy volunteers can take part
What is being tested?
Cruciate-Retaining Total Knee Arthroplasty and Posterior-Stabilized Total Knee Arthroplasty
How many people
40 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Apr 2025to 1 Jul 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The study population consisted of patients aged between 50 years and 65 years who were scheduled to undergo primary unilateral total knee arthroplasty at a single orthopedic center. All participants were Turkish-speaking, fully oriented, and capable of completing patient-reported outcome measures. The cohort included individuals who received surgery under standardized perioperative and postoperative care protocols. Patients with revision arthroplasty, neurological or neuromuscular disorders affecting gait, cognitive impairment, psychiatric disease, or major perioperative complications were not included in the study population.

Who may be able to join

  • Patients scheduled for primary unilateral total knee arthroplasty (TKA).
  • Ability to read and understand Turkish.
  • Full orientation in person, place, and time.
  • Voluntary participation with informed consent.
  • Surgery performed at the same institution under standardized perioperative and postoperative care protocols.

Who cannot join

  • Revision total knee arthroplasty.
  • Presence of neuromuscular or neurological disorders affecting gait (e.g., stroke, Parkinson disease, myopathies).
  • Cognitive impairment or diagnosed psychiatric disorders that may interfere with questionnaire completion or participation.
  • Perioperative complications such as excessive bleeding, infection, prosthesis dislocation, or deep venous thrombosis.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Ondokuz Mayis University

    Samsun, Atakum, 55270

Other trials in Turkey (Türkiye)

About this study

Official title: Recovery Trajectories After Cruciate Retaining And Posterior Stabilized Total Knee Arthroplasty

This prospective cohort study aimed to compare recovery trajectories following cruciate-retaining (CR) and posterior-stabilized (PS) total knee arthroplasty (TKA) using rehabilitation-centered patient-reported outcome measures (PROMs). Forty patients undergoing primary unilateral TKA were evaluated preoperatively and at 3 and 6 months postoperatively. Outcomes included pain intensity, functional status, kinesiophobia, health-related quality of life, and joint awareness assessed using validated PROMs including the Visual Analog Scale (VAS), WOMAC, Tampa Scale for Kinesiophobia (TSK), SF-36, and Forgotten Joint Score-12 (FJS-12). The study investigated whether posterior cruciate ligament management influences early postoperative recovery trajectories after TKA.

Read the detailed description

Total knee arthroplasty (TKA) is an effective surgical intervention for patients with advanced knee osteoarthritis who experience persistent pain and functional limitations despite conservative treatment. Among contemporary implant designs, cruciate-retaining (CR) and posterior-stabilized (PS) prostheses are the most widely used approaches. CR implants preserve the posterior cruciate ligament (PCL) to maintain more physiological knee kinematics, whereas PS implants substitute PCL function through a post-cam mechanism. Although both designs have demonstrated successful clinical outcomes, evidence regarding their comparative influence on postoperative recovery remains inconclusive.

In recent years, postoperative evaluation after TKA has increasingly emphasized rehabilitation-centered patient-reported outcome measures (PROMs) rather than solely clinician-based assessments. Parameters such as pain, functional status, quality of life, kinesiophobia, and joint awareness provide a more comprehensive understanding of patient recovery and adaptation after surgery. However, studies directly comparing CR and PS TKA from this multidimensional rehabilitation perspective remain limited.

This single-center prospective cohort study was conducted at the Department of Orthopedics and Traumatology, Ondokuz Mayıs University Health Application and Research Center. Patients aged 50 years or older undergoing primary unilateral TKA were included. Participants were allocated to CR or PS groups according to intraoperative surgical decision-making based on posterior cruciate ligament integrity, soft-tissue balance, and routine surgical practice. Standardized perioperative management and postoperative rehabilitation protocols were applied to all participants.

Pain intensity was assessed using the Visual Analog Scale (VAS), functional status with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), kinesiophobia with the Tampa Scale for Kinesiophobia (TSK), and health-related quality of life with the Short Form-36 Health Survey (SF-36). Joint awareness was evaluated postoperatively using the Forgotten Joint Score-12 (FJS-12). Assessments were performed preoperatively and repeated at 3 and 6 months after surgery.

The primary objective of the study was to compare longitudinal recovery trajectories between CR and PS TKA designs across rehabilitation-related PROMs. The study further aimed to determine whether posterior cruciate ligament management influences pain reduction, functional recovery, psychosocial adaptation, and joint awareness during the early postoperative period.

Being tested
Cruciate-Retaining Total Knee Arthroplasty, Posterior-Stabilized Total Knee Arthroplasty
Keywords
total knee arthroplasty, patient-reported outcome measures, forgotten joint score, cruciate-retaining, posterior-stabilized

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cruciate-Retaining Total Knee ArthroplastyOther

    Primary unilateral total knee arthroplasty performed using a cruciate-retaining implant design in which the posterior cruciate ligament (PCL) was preserved. Implant selection was based on intraoperative assessment of ligament integrity and soft-tissue balance. Standardized perioperative management and postoperative rehabilitation protocols were applied to all participants.

  • Posterior-Stabilized Total Knee ArthroplastyOther

    Primary unilateral total knee arthroplasty performed using a posterior-stabilized implant design incorporating a post-cam mechanism to substitute posterior cruciate ligament (PCL) function. Implant selection was determined intraoperatively according to ligament condition and soft-tissue balancing requirements. All participants received standardized perioperative care and postoperative rehabilitation.

Study groups in NCT07595861
Study groupRoleWhat they receive
Posterior-stabilized GroupParticipants in the posterior-stabilized (PS) group underwent primary unilateral total knee arthroplasty using a posterior cruciate ligament-substituting implant design with a post-cam stabilization mechanism. Implant selection was determined intraoperatively according to posterior cruciate ligament condition, soft-tissue balancing requirements, and standard surgical practice. All participants received standardized perioperative care and postoperative rehabilitation. Recovery trajectories were assessed using validated patient-reported outcome measures evaluating pain, function, kinesiophobia, quality of life, and joint awareness before surgery and at 3 and 6 months postoperatively.
Receives: Other: Posterior-Stabilized Total Knee Arthroplasty
Cruciate-Retaining GroupParticipants in the cruciate-retaining (CR) group underwent primary unilateral total knee arthroplasty using a posterior cruciate ligament-preserving implant design. Implant selection was determined intraoperatively based on posterior cruciate ligament integrity, soft-tissue balance, and routine surgical assessment. Patients received standardized perioperative management and postoperative rehabilitation protocols. Recovery outcomes were evaluated using patient-reported outcome measures including pain intensity, functional status, kinesiophobia, health-related quality of life, and joint awareness at preoperative, 3-month, and 6-month follow-up assessments.
Receives: Other: Cruciate-Retaining Total Knee Arthroplasty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Pain Intensity Assessed by Visual Analog Scale (VAS)

    The primary outcome measure is pain intensity evaluated using the 10-cm Visual Analog Scale (VAS). Patients indicate their perceived pain level on a continuous scale ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain severity. The VAS is a widely validated patient-reported outcome measure used to quantify subjective pain intensity in musculoskeletal and postoperative populations.

    Measured: Baseline

  2. Functional Status Assessed by Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    Functional status is evaluated using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), which assesses pain, stiffness, and physical function. The questionnaire consists of multiple items scored on a Likert scale. Higher total and subscale scores indicate worse symptoms and greater functional impairment. WOMAC is a validated disease-specific outcome measure commonly used in lower extremity musculoskeletal conditions.

    Measured: Baseline

  3. Fear of Movement Assessed by Tampa Scale for Kinesiophobia (TSK)

    Fear of movement and (re)injury is measured using the Tampa Scale for Kinesiophobia (TSK). The scale evaluates fear-related beliefs about physical activity and movement. It consists of multiple items rated on a Likert scale, with higher total scores indicating greater levels of kinesiophobia. The TSK is a validated tool widely used in musculoskeletal and postoperative rehabilitation populations.

    Measured: Baseline

  4. Health-Related Quality of Life Assessed by Short Form-36 (SF-36)

    Health-related quality of life is assessed using the Short Form-36 (SF-36) questionnaire, which includes eight domains: physical functioning, role limitations due to physical health, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Each domain is scored from 0 to 100, with higher scores indicating better perceived health status. SF-36 is a generic, validated quality-of-life instrument.

    Measured: Baseline

  5. Postoperative Joint Awareness Assessed by Forgotten Joint Score-12 (FJS-12)

    Postoperative joint awareness is evaluated using the Forgotten Joint Score-12 (FJS-12), a joint-specific patient-reported outcome measure designed to assess the ability of patients to "forget" the presence of an artificial or affected joint during daily activities. The score is transformed to a 0-100 scale, where higher scores indicate lower joint awareness and better functional integration of the joint in daily life. The FJS-12 has a low ceiling effect and high sensitivity in detecting subtle differences in joint perception.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 May 2026
  2. Study start1 Apr 2025
  3. Primary completion1 Jul 2025
  4. Study completion1 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07595861
Sponsor's protocol ID
OMU2025/182
Status last verified
Feb 2026
First submitted
12 May 2026
Last updated
19 May 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Total Knee Anthroplasty and Patient Reported Outcome Measurements, run by Ondokuz Mayıs University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Pain Intensity Assessed by Visual Analog Scale (VAS) (time frame: Baseline). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in